Are ezetimibe and Vascepa the same medication?
No. Ezetimibe and Vascepa (icosapent ethyl) are different drugs used to treat different aspects of lipid (fat) problems.
What is ezetimibe used for?
Ezetimibe is a cholesterol-lowering medicine. It works by reducing how much cholesterol the body absorbs from the intestine, which lowers LDL (“bad”) cholesterol.
What is Vascepa used for?
Vascepa (icosapent ethyl) is used to help reduce cardiovascular risk in certain people with high triglycerides, typically as an add-on to other care (such as statins) for people who meet specific criteria.
Do they work the same way?
No. They act on different targets:
- Ezetimibe lowers intestinal cholesterol absorption (mainly LDL cholesterol lowering).
- Vascepa is an omega-3–derived medication aimed at triglycerides and cardiovascular risk in appropriate patients (mainly triglyceride-related risk reduction, not the same mechanism as ezetimibe).
Can you take ezetimibe and Vascepa together?
In many clinical settings they can be used together because they treat different lipid issues (one for cholesterol absorption and the other for triglyceride-related risk). The exact combination depends on your lipid levels, diagnosis, and other medications—so a clinician should confirm it for your situation.
Which one treats “high cholesterol” vs “high triglycerides”?
- If the goal is lowering LDL (“bad”) cholesterol, ezetimibe is the more direct match.
- If the goal is addressing elevated triglycerides and related cardiovascular risk in eligible patients, Vascepa is the more direct match.
What should patients check when switching or comparing?
Patients should check the exact active ingredient:
- Ezetimibe tablet (cholesterol absorption blocker)
- Vascepa capsule (icosapent ethyl)
If you share your prescription label or your lab results (LDL and triglycerides) and any current meds, I can help explain which drug is typically being targeted.